Singapore’s Sovereign Wealth Fund Takes 1/3 Stake In Grifols’ US Subsidiary For $1 Billion
Grifols will use all the funds from the sale of Biomat to repay debt, approximately 14% of the €6.2 billion of net financial debt at the end of March, for a leverage level of 5.1 x EBITDA. Although it is not known what percentage of Biomat has been sold, some market sources put it at between 30% and 35%.